American biomedical researchers were reeling on Thursday after hearing reports from South Korea that members of a top team of scientists there had admitted to fabricating at least part of a landmark study on embryonic stem cells.
The revelations, the Americans said, had the potential to undermine research on cloning human embryos and developing embryonic-stem-cell lines for treating diseases such as Parkinson’s, Alzheimer’s, and diabetes.